Catheter-Related Bloodstream Infection Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Catheter-Related Bloodstream Infection Market?

The catheter-related bloodstream infection market has exhibited substantial growth in recent years. It is expected to expand from $1.53 billion in 2024 to $1.62 billion in 2025, at a compound annual growth rate (CAGR) of 5.9%. Historically, this growth can be attributed to the increasing incidence of chronic diseases, enhanced awareness and education, an uptick in hospital-acquired infections, the expanding elderly population, and strengthened infection control programs within hospitals and healthcare settings.

The market size for catheter-related bloodstream infections is anticipated to experience robust growth in the coming years. It is projected to expand to $2.01 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.6%. The expansion during the forecast period is attributable to an increase in healthcare-associated infections (HAIs), a surge in awareness and training, augmented awareness and training programs concerning infection control practices, the growth of healthcare infrastructure, a rise in the geriatric population, and encouraging government policies and initiatives. Significant trends expected in the forecast period include innovations in biomaterials, the advent of smart catheter technology, the creation of more potent catheter lock solutions possessing advanced antimicrobial properties, advancements in catheter sterilization processes, and the implementation of automated flushing systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

Which Drivers Are Impacting The Catheter-Related Bloodstream Infection Market?

The increasing incidence of hospital-acquired infections is projected to stimulate the expansion of the catheter-related bloodstream infection market. Hospital-acquired infections (HAIs) are conditions patients develop within a healthcare setting during treatment for other illnesses, typically emerging 48 hours or more after hospital entry. Various elements, such as antimicrobial resistance, inadequate infection control practices, and patient susceptibility, contribute to the rise in these infections. Catheter-related bloodstream infections play a substantial role in hospital-acquired infections due to their invasive nature and potential for microbial colonization, posing risks to individuals with indwelling catheters. For instance, in January 2023, the National Library of Medicine, a US-based biomedical library, indicated that the global healthcare-associated infection (HAI) rate was 0.14%, with an annual rise of 0.06%. Therefore, the growing prevalence of hospital-acquired infections will propel the growth of the catheter-related bloodstream infection market.

What Are The Key Segments In The Catheter-Related Bloodstream Infection Market?

The catheter-related bloodstream infectionmarket covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy; Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus; Acinetobacter Baumannii; Escherichia Coli (E. Coli); Klebsiella Pneumoniae (K. Pneumonia); Candida Species (Candida Sp.); Pseudomonas Aeruginosa (P. Aeruginosa); Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based); Combination Antibiotic Lock Therapy

2) By Anti-Microbial Agents: Antibiotics; Antifungal Agents; Antiseptic Agents

Which Ongoing Trends Are Expected To Shape The Catheter-Related Bloodstream Infection Market Outlook?

Major companies operating in the catheter-related bloodstream infection market are actively developing innovative catheter lock solutions, aiming to enhance infection prevention and improve patient outcomes. A catheter lock solution is a liquid introduced into a catheter to prevent infections and maintain its patency between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical company focused on developing and commercializing therapeutic products, obtained US Food and Drug Administration approval for DefenCath (taurolidine and heparin) catheter lock solution. This approval is for adult patients with kidney failure undergoing chronic hemodialysis via a central venous catheter (CVC). This antimicrobial and antifungal solution is specifically designed to reduce catheter-related bloodstream infections (CRBSIs), combining heparin for anticoagulation with taurolidine’s broad-spectrum antimicrobial properties.

Which Leading Players Are Enhancing Their Catheter-Related Bloodstream Infection Market Presence Worldwide?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

What Are The Key Regional Factors Influencing The Catheter-Related Bloodstream Infection Market Growth?

North America was the largest region in the catheter-related bloodstream infection market in 2024. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Catheter-Related Bloodstream Infection Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp

Browse Through More Reports Similar to the Global Catheter-Related Bloodstream Infection Market 2025, By The Business Research Company

Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Peripheral Iv Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Intravascular Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795